PerpEquities

Equity · Healthcare

Is Bristol Myers Squibb (BMY) tradable as a perp? Not yet

Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and commercializes medicines for diseases including cancer, cardiovascular, immunology, and neurology.

Not yet listed on any perp exchange

No perpetual-futures venue lists BMY yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
VRTXISRGPFEREGNGILDNVO

Price chart

Interactive TradingView chart

TradingView symbol NYSE:BMY

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 1h ago
Market cap
$128.8B
Updated 1h ago
Revenue
$49.2B
Trailing 12 months
Revenue growth
+3%
Next fiscal year
Profit margin
+18.9%
P/E
13.9
Peer P/E 18.1
Free cash flow
$11.4B
Trailing 12 months
More metrics
Net income
$9.3B
Trailing 12 months
P/S
2.6
Peer P/E
18.1
Similar listed perps
Revenue estimate
$49.6B
Next fiscal year
Earnings
2026-10-29
Revenue est. $12.6B · Updated 1h ago
Dividend
$0.63
2026-10-02

Fundamental detail

Annual + quarterly
Latest revenue$48.2B
Net margin+14.6%
Free cash flow$12.8B
Net debt$36.9B
2020$42.5B
2021$46.4B
2022$46.2B
2023$45B
2024$48.3B
2025$48.2B
PeriodRevenueGrowthNet incomeFCF
2020$42.5B+63%-$9B$13.3B
2021$46.4B+9%$7B$15.2B
2022$46.2B0%$6.3B$11.9B
2023$45B-2%$8B$12.7B
2024$48.3B+7%-$8.9B$13.9B
2025$48.2B0%$7.1B$12.8B
PeriodGross marginOperating marginNet marginROEROA
2020+51.0%+10.6%-21.2%-23.8%-7.6%
2021+57.7%+20.6%+15.1%+19.5%+6.4%
2022+57.4%+20.1%+13.7%+20.4%+6.5%
2023+56.3%+18.8%+17.8%+27.3%+8.4%
2024+56.8%+20.0%-18.5%-54.8%-9.7%
2025+71.1%+28.5%+14.6%+38.2%+7.8%
PeriodCashDebtNet debtCurrent ratio
2020$14.5B$51.7B$37.1B1.58
2021$14B$45.6B$31.6B1.52
2022$9.1B$40.7B$31.6B1.25
2023$11.5B$41.5B$30B1.43
2024$10.3B$51.2B$40.9B1.25
2025$10.2B$47.1B$36.9B1.26
PeriodMarket capEnterprise valueP/SP/E
2020$140.1B$177.2B3.3-15.6
2021$138.5B$170.1B3.019.8
2022$153.3B$184.8B3.324.2
2023$106.2B$136.2B2.413.2
2024$114.6B$155.5B2.4-12.8
2025$110.1B$147B2.315.6
Q3 2024$11.9B
Q4 2024$12.3B
Q1 2025$11.2B
Q2 2025$12.3B
Q3 2025$12.2B
Q4 2025$12.5B
Q1 2026$11.5B
Q2 2026$13B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$11.9B+8%$1.2B$5.3B
Q4 2024$12.3B+8%$72M$4.1B
Q1 2025$11.2B-6%$2.5B$1.7B
Q2 2025$12.3B+1%$1.3B$3.6B
Q3 2025$12.2B+3%$2.2B$6B
Q4 2025$12.5B+1%$1.1B$1.6B
Q1 2026$11.5B+3%$2.7B$757M
Q2 2026$13B+6%$3.3B$3.1B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+55.6%+19.2%+10.2%+7.1%+1.3%
Q4 2024+60.2%+20.5%+0.6%+0.4%+0.1%
Q1 2025+72.9%+31.2%+21.9%+14.1%+2.7%
Q2 2025+72.5%+30.8%+10.7%+7.5%+1.4%
Q3 2025+71.9%+29.8%+18.0%+11.9%+2.3%
Q4 2025+67.2%+22.5%+8.7%+5.9%+1.2%
Q1 2026+70.2%+29.3%+23.3%+13.3%+3.1%
Q2 2026+71.3%+31.5%+25.6%+14.9%+3.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$7.9B$51.4B$43.5B1.24
Q4 2024$10.3B$51.2B$40.9B1.25
Q1 2025$10.9B$51.2B$40.4B1.28
Q2 2025$12.6B$50.9B$38.3B1.21
Q3 2025$15.7B$51B$35.3B1.27
Q4 2025$10.2B$47.1B$36.9B1.26
Q1 2026$9.6B$46.4B$36.9B1.42
Q2 2026$8.7B$43.1B$34.4B1.53
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$104.9B$148.4B8.821.6
Q4 2024$114.8B$155.6B9.3398.3
Q1 2025$123.9B$164.2B11.112.6
Q2 2025$94.2B$132.5B7.718.1
Q3 2025$91.9B$127.2B7.510.4
Q4 2025$110.1B$147B8.825.4
Q1 2026$123.9B$160.8B10.811.6
Q2 2026$117.7B$152.1B9.18.9

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$13BQ2 2026
$3.2B$6.5B$9.7B$13BQ3 2023: $11BQ4 2023: $11.5BQ1 2024: $11.9BQ2 2024: $12.2BQ3 2024: $11.9BQ4 2024: $12.3BQ1 2025: $11.2BQ2 2025: $12.3BQ3 2025: $12.2BQ4 2025: $12.5BQ1 2026: $11.5BQ2 2026: $13BQ3 2023Q2 2026
Net income$3.3BQ2 2026
-$8.1B-$4.3B-$490M$3.3BQ3 2023: $1.9BQ4 2023: $1.8BQ1 2024: -$11.9BQ2 2024: $1.7BQ3 2024: $1.2BQ4 2024: $72MQ1 2025: $2.5BQ2 2025: $1.3BQ3 2025: $2.2BQ4 2025: $1.1BQ1 2026: $2.7BQ2 2026: $3.3BQ3 2023Q2 2026
EBITDA$4.9BQ2 2026
-$5.2B-$1.8B$1.6B$4.9BQ3 2023: $4.9BQ4 2023: $4.5BQ1 2024: -$8.6BQ2 2024: $4.4BQ3 2024: $4.8BQ4 2024: $2.6BQ1 2025: $4.5BQ2 2025: $3.3BQ3 2025: $4.6BQ4 2025: $2.9BQ1 2026: $4.2BQ2 2026: $4.9BQ3 2023Q2 2026
Free cash flow$3.1BQ2 2026
$1.5B$3B$4.5B$6BQ3 2023: $4.4BQ4 2023: $3.9BQ1 2024: $2.6BQ2 2024: $2.1BQ3 2024: $5.3BQ4 2024: $4.1BQ1 2025: $1.7BQ2 2025: $3.6BQ3 2025: $6BQ4 2025: $1.6BQ1 2026: $757MQ2 2026: $3.1BQ3 2023Q2 2026
EPS$1.62Q2 2026
-$4.01-$2.14-$0.26$1.62Q3 2023: $0.93Q4 2023: $0.87Q1 2024: -$5.89Q2 2024: $0.83Q3 2024: $0.6Q4 2024: $0.04Q1 2025: $1.2Q2 2025: $0.64Q3 2025: $1.08Q4 2025: $0.53Q1 2026: $1.31Q2 2026: $1.62Q3 2023Q2 2026
Cash / Debt$8.7BQ2 2026
$14.4B$28.7B$43.1B$57.4BQ3 2023 · Cash: $7.5BQ3 2023 · Debt: $39.3BQ4 2023 · Cash: $11.5BQ4 2023 · Debt: $41.5BQ1 2024 · Cash: $9.3BQ1 2024 · Debt: $57.4BQ2 2024 · Cash: $6.3BQ2 2024 · Debt: $54BQ3 2024 · Cash: $7.9BQ3 2024 · Debt: $51.4BQ4 2024 · Cash: $10.3BQ4 2024 · Debt: $51.2BQ1 2025 · Cash: $10.9BQ1 2025 · Debt: $51.2BQ2 2025 · Cash: $12.6BQ2 2025 · Debt: $50.9BQ3 2025 · Cash: $15.7BQ3 2025 · Debt: $51BQ4 2025 · Cash: $10.2BQ4 2025 · Debt: $47.1BQ1 2026 · Cash: $9.6BQ1 2026 · Debt: $46.4BQ2 2026 · Cash: $8.7BQ2 2026 · Debt: $43.1BQ3 2023Q2 2026
CashDebt
Profitability+71.3%Q2 2026
-57.1%-13.7%+29.6%+72.9%Q3 2023 · Gross margin: +56.7%Q4 2023 · Gross margin: +56.6%Q1 2024 · Gross margin: +55.5%Q2 2024 · Gross margin: +55.7%Q3 2024 · Gross margin: +55.6%Q4 2024 · Gross margin: +60.2%Q1 2025 · Gross margin: +72.9%Q2 2025 · Gross margin: +72.5%Q3 2025 · Gross margin: +71.9%Q4 2025 · Gross margin: +67.2%Q1 2026 · Gross margin: +70.2%Q2 2026 · Gross margin: +71.3%Q3 2023 · Operating margin: +19.2%Q4 2023 · Operating margin: +17.0%Q1 2024 · Operating margin: +12.9%Q2 2024 · Operating margin: +21.2%Q3 2024 · Operating margin: +19.2%Q4 2024 · Operating margin: +20.5%Q1 2025 · Operating margin: +31.2%Q2 2025 · Operating margin: +30.8%Q3 2025 · Operating margin: +29.8%Q4 2025 · Operating margin: +22.5%Q1 2026 · Operating margin: +29.3%Q2 2026 · Operating margin: +31.5%Q3 2023 · Net margin: +17.6%Q4 2023 · Net margin: +15.4%Q1 2024 · Net margin: -100.4%Q2 2024 · Net margin: +13.8%Q3 2024 · Net margin: +10.2%Q4 2024 · Net margin: +0.6%Q1 2025 · Net margin: +21.9%Q2 2025 · Net margin: +10.7%Q3 2025 · Net margin: +18.0%Q4 2025 · Net margin: +8.7%Q1 2026 · Net margin: +23.3%Q2 2026 · Net margin: +25.6%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+5.7%Q2 2026
-2.1%+1.4%+4.9%+8.4%Q3 2024: +8.4%Q4 2024: +7.5%Q1 2025: -5.6%Q2 2025: +0.6%Q3 2025: +2.8%Q4 2025: +1.3%Q1 2026: +2.6%Q2 2026: +5.7%Q3 2023Q2 2026
Shares outstanding2BQ2 2026
516M1B1.5B2.1BQ3 2023: 2.1BQ4 2023: 2BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2BQ4 2024: 2BQ1 2025: 2BQ2 2025: 2BQ3 2025: 2BQ4 2025: 2BQ1 2026: 2BQ2 2026: 2BQ3 2023Q2 2026
Valuation8.9Q2 2026
97.9198.0298.2398.3Q3 2023 · P/E: 15.4Q4 2023 · P/E: 14.7Q1 2024 · P/E: -2.2Q2 2024 · P/E: 12.4Q3 2024 · P/E: 21.6Q4 2024 · P/E: 398.3Q1 2025 · P/E: 12.6Q2 2025 · P/E: 18.1Q3 2025 · P/E: 10.4Q4 2025 · P/E: 25.4Q1 2026 · P/E: 11.6Q2 2026 · P/E: 8.9Q3 2023 · P/S: 10.9Q4 2023 · P/S: 9.1Q1 2024 · P/S: 9.0Q2 2024 · P/S: 6.9Q3 2024 · P/S: 8.8Q4 2024 · P/S: 9.3Q1 2025 · P/S: 11.1Q2 2025 · P/S: 7.7Q3 2025 · P/S: 7.5Q4 2025 · P/S: 8.8Q1 2026 · P/S: 10.8Q2 2026 · P/S: 9.1Q3 2023Q2 2026
P/EP/S
Revenue$48.2B2025
$12.1B$24.2B$36.2B$48.3B2018: $22.6B2019: $26.1B2020: $42.5B2021: $46.4B2022: $46.2B2023: $45B2024: $48.3B2025: $48.2B20182025
Net income$7.1B2025
-$4.7B-$485M$3.8B$8B2018: $4.9B2019: $3.4B2020: -$9B2021: $7B2022: $6.3B2023: $8B2024: -$8.9B2025: $7.1B20182025
EBITDA$15.2B2025
$5B$10.1B$15.1B$20.1B2018: $6.8B2019: $7.4B2020: $4.9B2021: $20.1B2022: $19.2B2023: $19.4B2024: $3.2B2025: $15.2B20182025
Free cash flow$12.8B2025
$3.8B$7.6B$11.4B$15.2B2018: $6.1B2019: $7.4B2020: $13.3B2021: $15.2B2022: $11.9B2023: $12.7B2024: $13.9B2025: $12.8B20182025
EPS$3.452025
-$2.34-$0.28$1.79$3.862018: $3.032019: $2.012020: -$3.982021: $3.122022: $2.952023: $3.862024: -$4.412025: $3.4520182025
Cash / Debt$10.2B2025
$12.9B$25.8B$38.8B$51.7B2018 · Cash: $6.9B2018 · Debt: $7.3B2019 · Cash: $12.3B2019 · Debt: $47.5B2020 · Cash: $14.5B2020 · Debt: $51.7B2021 · Cash: $14B2021 · Debt: $45.6B2022 · Cash: $9.1B2022 · Debt: $40.7B2023 · Cash: $11.5B2023 · Debt: $41.5B2024 · Cash: $10.3B2024 · Debt: $51.2B2025 · Cash: $10.2B2025 · Debt: $47.1B20182025
CashDebt
Profitability+71.1%2025
+1.9%+25.0%+48.1%+71.3%2018 · Gross margin: +71.3%2019 · Gross margin: +66.0%2020 · Gross margin: +51.0%2021 · Gross margin: +57.7%2022 · Gross margin: +57.4%2023 · Gross margin: +56.3%2024 · Gross margin: +56.8%2025 · Gross margin: +71.1%2018 · Operating margin: +28.3%2019 · Operating margin: +24.6%2020 · Operating margin: +10.6%2021 · Operating margin: +20.6%2022 · Operating margin: +20.1%2023 · Operating margin: +18.8%2024 · Operating margin: +20.0%2025 · Operating margin: +28.5%2018 · Net margin: +21.8%2019 · Net margin: +13.2%2020 · Net margin: -21.2%2021 · Net margin: +15.1%2022 · Net margin: +13.7%2023 · Net margin: +17.8%2024 · Net margin: -18.5%2025 · Net margin: +14.6%20182025
Gross marginOperating marginNet margin
Revenue growth-0.2%2025
+13.8%+30.1%+46.3%+62.6%2019: +15.9%2020: +62.6%2021: +9.1%2022: -0.5%2023: -2.5%2024: +7.3%2025: -0.2%20182025
Shares outstanding2B2025
564.5M1.1B1.7B2.3B2018: 1.6B2019: 1.7B2020: 2.3B2021: 2.2B2022: 2.1B2023: 2.1B2024: 2B2025: 2B20182025
Valuation15.62025
-3.78.119.931.82018 · P/E: 17.22019 · P/E: 31.82020 · P/E: -15.62021 · P/E: 19.82022 · P/E: 24.22023 · P/E: 13.22024 · P/E: -12.82025 · P/E: 15.62018 · P/S: 3.82019 · P/S: 4.22020 · P/S: 3.32021 · P/S: 3.02022 · P/S: 3.32023 · P/S: 2.42024 · P/S: 2.42025 · P/S: 2.320182025
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20266.95$49.6B+3%16
FY 20276.56$48.1B0%16
FY 20285.64$42B-13%8
FY 20295.08$38B-21%5
FY 20305.00$37.5B-22%5
Q1 20271.45$11.2B-3%8

Company events

6
2026-10-29EarningsActual - / Estimate 1.68-
2026-10-02Dividend$0.63-
2026-07-30EarningsActual 2.04 / Estimate 1.6Beat
2026-07-02Dividend$0.63-
2026-04-30EarningsActual 1.58 / Estimate 1.42Beat
2026-04-02Dividend$0.63-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
VRTX$129B10.229.3+34.9%3ISRG$139B12.644.4+28.4%8PFE$157.3B2.536.5+6.8%3REGN$80.8B5.218.7+27.9%6GILD$186.4B6.1-57.7-10.6%7NVO$192B3.810.7+35.3%14BSX$64.4B3.117.5+17.5%2MRNA$61.1B27.4-19.3-141.4%21

Analyst track record

How the analysts covering BMY have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings196504
Analysts2745
Buy / hold / sell68 / 117 / 11148 / 316 / 40
Upgrades / downgrades / initiations5 / 0 / 39 / 10 / 9
Price targets hit / missed97 / 62 (61%)296 / 119 (71%)
Avg. return after a rating (TipRanks)+8.4%+13.1%
Best / worst call+84.8% / -23.4%+84.8% / -45.4%

After buy calls on this stock: median 21-day move +0.2% vs S&P 500 -0.7% (n = 153)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. David RisingerLeerink Partners38% hit rate on this stock · 8 targets measuredBuytarget $60.00Jan 13, 2026
  2. Chris SchottJ.P. Morgan31% hit rate on this stock · 13 targets measuredBuytarget $73.00Aug 4, 2026
  3. Terence FlynnMorgan Stanley24% hit rate on this stock · 21 targets measuredSelltarget $40.00Aug 14, 2026

Latest ratings

DateAnalystCallTarget
Sep 16, 2026David AmsellemPiper SandlerBuyReiterated$82.00article ↗
Sep 16, 2026David AmsellemPiper SandlerBuyReiterated$82.00
Sep 14, 2026Trung HuynhRBC CapitalHoldMaintained$64.00article ↗
Sep 14, 2026Trung HuynhRBC CapitalHoldMaintained$64.00
Sep 10, 2026Rajesh KumarHSBCHoldMaintained$65.00article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$45.00$50.00$55.00$60.00$65.00Oct 25 · Buy 5 · Hold 13 · Sell 1Oct 25Nov 25 · Buy 5 · Hold 14 · Sell 1Dec 25 · Buy 8 · Hold 15 · Sell 1Dec 25Jan 26 · Buy 9 · Hold 13 · Sell 1Feb 26 · Buy 9 · Hold 13 · Sell 1Feb 26Mar 26 · Buy 9 · Hold 13 · Sell 1Apr 26 · Buy 9 · Hold 13 · Sell 1Apr 26May 26 · Buy 9 · Hold 14 · Sell 1Jun 26 · Buy 9 · Hold 14 · Sell 1Jun 26Jul 26 · Buy 8 · Hold 13 · Sell 1Aug 26 · Buy 9 · Hold 13 · Sell 1Aug 26Sep 26 · Buy 9 · Hold 13 · Sell 1Oct 25 · avg. target $51.13Nov 25 · avg. target $51.40Dec 25 · avg. target $52.59Jan 26 · avg. target $56.37Feb 26 · avg. target $60.35Mar 26 · avg. target $61.65Apr 26 · avg. target $62.26May 26 · avg. target $62.63Jun 26 · avg. target $62.89Jul 26 · avg. target $65.10Aug 26 · avg. target $66.40Sep 26 · avg. target $67.00Oct 25 · month-end close $46.07Nov 25 · month-end close $49.20Dec 25 · month-end close $53.94Jan 26 · month-end close $55.05Feb 26 · month-end close $62.37Mar 26 · month-end close $60.65Apr 26 · month-end close $60.59May 26 · month-end close $57.18Jun 26 · month-end close $57.62Jul 26 · month-end close $65.31Aug 26 · month-end close $66.81Sep 26 · month-end close $62.84

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 196 ratings